[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366298-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-366298-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","clinical-significance-of-s-isoform-of-dclk1-in-different-gastric-cancer-subtypes-using-newly-produced-monoclonal-antibody","Clinical significance of “S” isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody","","Background: Doublecortin-like kinase 1 (DCLK1) isoforms have distinct roles in gastrointestinal cancer progression. This study generated DCLK1-S-specific monoclonal antibodies (mAbs) to assess the clinical value of DCLK1-S in gastric cancer. Materials and methods: Mice were immunized with a 7-mer synthetic peptide of DCLK1-S conjugated to KLH, and hybridomas/mAbs were evaluated by ELISA and immunohistochemistry (IHC). DCLK1-S expression was examined in gastric cancer cell lines (flow cytometry) and in 217 tumor samples plus 28 adjacent normal tissues via tissue microarrays, with analysis of prognostic associations. Results: The mAbs showed strong peptide-specific immunoreactivity and recognized DCLK1-S on the cell surface. DCLK1-S localization varied among membranous, cytoplasmic, and nuclear patterns. Expression associations differed by histological subtype and were linked to invasion-related parameters and survival trends. Conclusion: A precise tool for detecting DCLK1-S in cancer tissues was developed, and DCLK1-S overexpression may reflect favorable clinical relevance in gastric cancer.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-significance-of-s-isoform-of-dclk1-in-different-gastric-cancer-subtypes-using-newly-produced-monoclonal-antibody/366298/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-significance-of-s-isoform-of-dclk1-in-different-gastric-cancer-subtypes-using-newly-produced-monoclonal-antibody/366298.png","ImageObject",300,407,{"name":42,"@type":43},"Adam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the study regarding DCLK1-S?","Question",{"text":63,"@type":64},"To generate DCLK1-S-specific monoclonal antibodies and evaluate the clinical value of DCLK1-S in gastric cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the newly produced monoclonal antibodies characterized?",{"text":68,"@type":64},"Hybridomas and mAbs were assessed by ELISA and immunohistochemistry (IHC), and DCLK1-S recognition on cells was confirmed by flow cytometry.",{"name":70,"@type":61,"acceptedAnswer":71},"How did DCLK1-S expression relate to clinicopathologic features across gastric cancer subtypes?",{"text":72,"@type":64},"The study found subtype-dependent associations between DCLK1-S localization (membrane, cytoplasm, nuclear) and parameters such as PT stage and invasion; signet ring cells showed different trends.",{"name":74,"@type":61,"acceptedAnswer":75},"What was the conclusion about DCLK1-S in gastric cancer?",{"text":76,"@type":64},"An efficient and precise detection tool for DCLK1-S was developed, and DCLK1-S overexpression may represent a favorable clinical factor in gastric cancer patients.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},366298,1790463011,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Clinical signiﬁcance of “S” isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody  \nCancer Biomarkers Vol. 42(1): 1–25 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592241301691](DOI: 10.1177/18758592241301691)[ ](DOI: 10.1177/18758592241301691)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nMahdieh Razmi 1, Ali-Ahmad Bayat2, Naﬁseh Mortazavi3, Elham Kalantari 1, Leili Saeednejad Zanjani 1,4, Sima Saki 1, Roya Ghods 1,5 and Zahra Madjd 1,3,5   \nAbstract  \nBackground: Doublecortin-like kinase 1 (DCLK1) isoforms play distinct roles in the progression of gastrointestinal cancers. For the ﬁrst time ever, the current study aimed to generate DCLK1-S-speciﬁc monoclonal antibodies (mAbs) to evaluate the clinical value of DCLK1-S (short isoform) in gastric cancer (GC).  \nMaterials and methods: Mice were immunized with a unique 7-mer synthetic peptide of DCLK1-S conjugated with keyhole limpet hemocyanin (KLH). Immunoreactivity of hybridomas and mAbs was determined by ELISA assays and immunohistochemistry (IHC). DCLK1-S expression in two GC cell lines was assessed by ﬂow cytometry. After characterization, the expression pattern of DCLK1-S was investigated in different histological subtypes of GC (n=217) and adjacent normal tissues (n=28) using IHC on tissue microarrays. The association of clinical prognostic values with DCLK1-S expression was also investigated. Results: ELISA ﬁndings demonstrated that the generated monoclonal antibody (mAb) exhibited strong immunoreactivity towards the immunizing peptide. Positive control tissues, including GC and colorectal cancer, showed strong positive immunoreactivity with anti-DCLK1-S mAb whereas negative reagent control sections represented no staining, demonstrating the speciﬁcity of produced mAb. Flow cytometry analysis conﬁrmed that the newly developed mAbs effectively recognized DCLK1-S on the cell surface. A mixture pattern of membranous, cytoplasmic, and nuclear DCLK1-S expression in the GC cells was observed. A signiﬁcant and inverse association was identiﬁed between the expression DCLK1-Sin the cell membrane and cytoplasm and PT stage, muscolarispropia, subserosa, and perineural invasion in intestinal subtype, respectively. In signet ring cell type, however, nuclear DCLK1-S expression was adversely associated with tumor size and PT stage. Furthermore, patients with low DCLK1-S expression had a shorter survival than patients with high expression, however, without a statistically signiﬁcant association.  \nConclusion: An efﬁcient and precise tool for detecting DCLK1-S in cancer tissues has been developed. Moreover, DCLK1-S overexpression might be considered a favorable clinical factor in GC patients.  \nKeywords  \nshort isoform of doublecortin-like kinase 1 (DCLK1-S), hybridoma technique, monoclonal antibody (mAb), gastric cancer, immunohistochemistry, tissue microarray  \nReceived: 5 March 2024; accepted: 31 October 2024  \n1 Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran  \n2Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran 3Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran  \n4Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA 5Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran  \nCorresponding authors:  \nZahra Madjd, Oncopathology Research Center, Department of Molecular Medicine, Iran University of Medical Sciences (IUMS), Hemmat Street (Highway), Next to Milad Tower, Tehran, Iran.  \n[Emails: Zahra.madjd@yahoo.com](Emails: Zahra.madjd@yahoo.com); [majdjabari.z@iums.ac.ir](majdjabari.z@iums","cbCaitsiYHX1mTHT","https://ap.wps.com/l/cbCaitsiYHX1mTHT","pdf",4607454,25,"English","# Abstract\n## Background\n## Materials and methods\n## Results\n## Conclusion\n# Introduction\n## Gastric cancer burden and challenges\n## Cancer stem cells and biomarker rationale","[{\"question\":\"What was the main goal of the study regarding DCLK1-S?\",\"answer\":\"To generate DCLK1-S-specific monoclonal antibodies and evaluate the clinical value of DCLK1-S in gastric cancer.\"},{\"question\":\"How were the newly produced monoclonal antibodies characterized?\",\"answer\":\"Hybridomas and mAbs were assessed by ELISA and immunohistochemistry (IHC), and DCLK1-S recognition on cells was confirmed by flow cytometry.\"},{\"question\":\"How did DCLK1-S expression relate to clinicopathologic features across gastric cancer subtypes?\",\"answer\":\"The study found subtype-dependent associations between DCLK1-S localization (membrane, cytoplasm, nuclear) and parameters such as PT stage and invasion; signet ring cells showed different trends.\"},{\"question\":\"What was the conclusion about DCLK1-S in gastric cancer?\",\"answer\":\"An efficient and precise detection tool for DCLK1-S was developed, and DCLK1-S overexpression may represent a favorable clinical factor in gastric cancer patients.\"}]","Clinical significance of “S” isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody | PDF",1790164656,63,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bd56c6e8d140f65c410287826df36e2.webp",983,1310,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41beb9baaabc69d28747128cffb912bc.webp",982,1309,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa021f9a71ed83e29d6a5f5b14cd8208.webp",981,1308,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/debc29762d21d6adcab909c60fbce720.webp",980,1306]